SEPTInvestingStart Free

MED SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on · accession 0000884546-26-000396

MED filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Medifast Inc (MED) common stock. The stock moved -0.5% by the first close after the filing.

Summary of the filing

A Schedule 13G/A amendment was filed regarding beneficial ownership of Medifast Inc (MED) common stock. The filing indicates a change in a holder's passive ownership position.

For details, click here →

Key details

IssuerMedifast Inc

How MED stock reacted

Close before

$11.65

Aug 11, 2026

First close after

-0.52%

$11.59

5 trading days

-3.09%

$11.29

Since filing

+9.96%

$12.81

✦ Ask GOAX AI about this filing — what it means for MED, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MED?

Click here

Frequently asked questions

What did MED file with the SEC on Aug 12, 2026?

MED filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Medifast Inc (MED) common stock. The filing indicates a change in a holder's passive ownership position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did MED stock react to this filing?

MED closed at $11.65 before the filing and $11.59 on Aug 12, 2026 (-0.52%). Five trading days later: $11.29 (-3.09%).

Other MED SEC filings

Get alerts when MED files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MED overviewMED analysisMED newsLatest SEC filings